QDs have demonstrated extensive potential in biomedical applications owing to the combination of their unique photophysical properties and the ability to render them biocompatible and specific by ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

End-of-life hardware strategy creates win-win scenario for miners and hosting facilities in fluctuating markets.

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor ...

But when U.S. National Institute of Standards and Technology researchers Christina Bergonzo and Alexander Grishaev put ...

A grassroots organization that formed with the goal of recalibrating cancer care around patient needs issued guidance ...

The promise of $300 billion annually in climate finance for lower-income countries by 2035 — recently announced at COP29 — ...

Höegh Evi, in partnership with Wärtsilä Gas Solutions, has announced the completion of the world’s first floating ...

Nearly a year after winning an accelerated approval for its DLL3-targeting small cell lung cancer (SCLC) therapy Imdelltra, ...

The data could help the Enhertu regimen overtake a drug combination that’s been used as the initial treatment for ...

The European Securities and Markets Authority (ESMA) has published a consultation paper setting out draft regulatory technical standards ...